Loading...
XHKG
8189
Market cap131mUSD
May 09, Last price  
0.47HKD
1D
-2.08%
1Q
1.08%
Jan 2017
-36.49%
Name

Tianjin TEDA Biomedical Engineering Co Ltd

Chart & Performance

D1W1MN
XHKG:8189 chart
No data to show
P/E
—
P/S
2.47
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
1.45%
Revenues
385m
-3.14%
205,031,866270,639,221327,954,880422,511,561432,000,259429,057,203511,150,674677,640,122583,111,851552,041,373501,589,528389,278,236375,906,530351,897,658358,751,734369,355,184476,384,723449,675,951397,998,097385,482,322
Net income
-28m
L+37.91%
772,7463,034,418-11,377,409-8,987,6025,148,7796,142,04214,417,02624,017,31721,373,60517,787,42825,564,5125,970,713-13,752,052-177,679,819-88,810,696-50,363,356-44,784,407-26,645,819-20,159,658-27,802,241
CFO
0k
P
8,782,4601,281,10359,342,567-25,579,7435,975,653-15,921,835-36,261,42728,083,421-10,652,04419,427,774-31,805,169-7,437,03417,399,979-21,840,410-3,798,54035,987,592-6,683,968-12,821,438-13,154,7100
Earnings
May 16, 2025

Profile

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. The company operates in two segments, Biological Compound Fertilizers Products, and Elderly Care and Health Care Services. Its biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formula that are used for the facilitation of balanced growth of grains, fruits, and vegetables. The company is also involved in the provision of integrated elderly and health care; and elderly equipment leasing services, as well as consulting, advisory, and assessment services. In addition, it provides and licenses electroencephalography photography (EEG) diagnosis detection services; and conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation business; and provision of soil environmental quality standards research services. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.
URL
http://www.bioteda.com/
IPO date
Jun 18, 2002
Employees
265
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
385,482
-3.14%
397,998
-11.49%
449,676
-5.61%
Cost of revenue
403,877
407,857
471,906
Unusual Expense (Income)
NOPBT
(18,394)
(9,859)
(22,230)
NOPBT Margin
Operating Taxes
221
(1,044)
151
Tax Rate
NOPAT
(18,616)
(8,815)
(22,381)
Net income
(27,802)
37.91%
(20,160)
-24.34%
(26,646)
-40.50%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
136,231
63,262
60,779
Long-term debt
34,059
32,169
74,446
Deferred revenue
Other long-term liabilities
1,338
(2,564)
Net debt
144,711
89,497
125,676
Cash flow
Cash from operating activities
(13,155)
(12,821)
CAPEX
(2,468)
(8,798)
Cash from investing activities
(467)
(12,931)
Cash from financing activities
12,729
6,169
FCF
(52,234)
7,930
(9,237)
Balance
Cash
25,400
5,934
9,549
Long term investments
180
Excess cash
6,306
Stockholders' equity
(246,878)
(193,897)
(178,481)
Invested Capital
436,571
342,034
352,515
ROIC
ROCE
EV
Common stock shares outstanding
1,894,500
1,894,500
1,894,500
Price
0.33
265.17%
0.09
 
Market cap
615,712
265.17%
168,610
 
EV
766,714
272,736
EBITDA
(18,394)
1,774
(6,840)
EV/EBITDA
153.71
Interest
5,173
6,402
Interest/NOPBT